Precision Cancer Medicine
  • About Precision Cancer Medicine
    • What is Precision Cancer Medicine?
    • How does Precision Cancer Medicine work?
    • Why is Precision Cancer Medicine Important?
    • The Future of Precision Cancer Medicine
      • Request a Consultation

        To schedule a consultation with an oncologist at Dana-Farber/Brigham and Women's Cancer Center, please call one of our experienced appointment coordinators.

        877-442-7898
        fill out the online form
  • Patient & Physician Resources
    • Questions to Ask Your Doctor
    • Patient Resources
    • Physician Resources
    • Glossary
      • Request a Consultation

        To schedule a consultation with an oncologist at Dana-Farber/Brigham and Women's Cancer Center, please call one of our experienced appointment coordinators.

        877-442-7898
        fill out the online form
  • Research & Treatment
    • Explore by Cancer
      • Breast Cancer
      • Hematology Oncology
      • Cutaneous (Skin) Cancer
      • Melanoma
      • Gastrointestinal Cancer
      • Neuro-Oncology
      • Genitourinary Cancer
      • Pediatric Hematology/Oncology
      • Gynecologic Cancer
      • Sarcoma
      • Head and Neck Cancer
      • Thoracic (Lung) Cancer
      • Research Collaboration
      • What is Profile?
      • Find Clinical Trials
      • Our Team
    • Consultation
      • Request a Consultation

        To schedule a consultation with an oncologist at Dana-Farber/Brigham and Women's Cancer Center, please call one of our experienced appointment coordinators.

        877-442-7898
        fill out the online form
  • Contact Us

Posts Categorized: Gastrointestinal Cancer

Researchers identify early sign of pancreatic cancer

Posted 6:24 pm by Michelle Chambers & filed under About, Gastrointestinal Cancer, News.

http://www.dana-farber.org/Newsroom/News-Releases/Researchers-identify-early-sign-of-pancreatic-cancer.aspx

Many patients with rare gastrointestinal tumor receive long-term benefit from targeted therapy, researchers report

Posted 9:15 pm by Michelle Chambers & filed under About, Gastrointestinal Cancer, News.

http://www.dana-farber.org/Newsroom/News-Releases/many-patients-with-rare-gastrointestinal-tumor-receive-long-term-benefit-from-targeted-therapy-researchers-report.aspx

FDA approves first targeted drug for advanced stomach cancer

Posted 9:17 pm by Michelle Chambers & filed under About, Gastrointestinal Cancer, News.

http://www.dana-farber.org/Newsroom/News-Releases/fda-approves-first-targeted-drug-for-advanced-stomach-cancer.aspx

Some patients with incurable tumors and BRCA mutations respond to new two-drug combination

Posted 10:22 pm by Michelle Chambers & filed under About, Gastrointestinal Cancer, News.

http://www.dana-farber.org/Newsroom/News-Releases/some-patients-with-incurable-tumors-and-brca-mutations-respond-to-new-two-drug-combination.aspx

Find Clinical Trials

To find clinical trials that focus on targeted therapies, use the pulldown menus below or enter a term in the search box.

  • Request a Consultation

    To schedule a consultation with an oncologist at Dana-Farber/Brigham and Women's Cancer Center, please call one of our experienced appointment coordinators.

    877-442-7898
    fill out the online form
  • Home

    About Us

    • Brigham and Women’s Hospital
    • Dana-Farber Cancer Institute
    • News
    • Video Library
    • About Precision Cancer Medicine
    • Patient & Physician Resources
    • Research & Treatment
    • Contact Us

    Explore By Cancer

    • Breast Cancer
    • Hematology Oncology
    • Cutaneous (Skin) Cancer
    • Melanoma
    • Gastrointestinal Cancer
    • Neuro-Oncology
    • Genitourinary Cancer
    • Pediatric Hematology/Oncology
    • Gynecologic Cancer
    • Sarcoma
    • Head and Neck Cancer
    • Thoracic (Lung) Cancer

    © 2026 Dana-Farber / Brigham and Women’s Cancer Center, Boston, MA Privacy PolicyLegal Statements